HBM4EU results support the Chemicals' Strategy for Sustainability and the Zero-Pollution Action Plan.

HBM4EU Human biomonitoring (HBM) Indicators Prioritisation Residents Science to policy

Journal

International journal of hygiene and environmental health
ISSN: 1618-131X
Titre abrégé: Int J Hyg Environ Health
Pays: Germany
ID NLM: 100898843

Informations de publication

Date de publication:
03 2023
Historique:
received: 16 09 2022
revised: 12 12 2022
accepted: 05 01 2023
pubmed: 28 1 2023
medline: 8 2 2023
entrez: 27 1 2023
Statut: ppublish

Résumé

One of the major goals of the European Human Biomonitoring Initiative (HBM4EU) was to bridge the gap between science and policy by consulting both policy makers and national scientists and generating evidence of the actual exposure of residents to chemicals and whether that exposure would be suggest a potential health risk. Residents' perspectives on chemical exposure and risk were also investigated. HBM4EU's research was designed to answer specific short-term and long-term policy questions at national and European levels, and for its results to directly support regulatory action on chemicals. A strategy was established to prioritise chemicals for analysis in human matrices, with a total of 18 substances/substance groups chosen to be investigated throughout the five-and a -half-year project. HBM4EU produced new evidence of human exposure levels, developed reference values for exposure, investigated determinants of exposure and derived health-based guidance values for those substances. In addition, HBM4EU promoted the use of human biomonitoring data in chemical risk assessment and developed innovative tools and methods linking chemicals to possible health impacts, such as effect biomarkers. Furthermore, HBM4EU advanced understand of effects from combined exposures and methods to identify emerging chemicals. With the aim of supporting policy implementation, science-to-policy workshops were organised, providing opportunities for joint reflection and dialogue on research results. I, and indicators were developed to assess temporal and spatial patterns in the exposure of European population. A sustainable human biomonitoring monitoring framework, producing comparable quality assured data would allow: the evaluation of time trends; the exploration of spatial trends: the evaluation of the influence of socio-economic conditions on chemical exposure. Therefore, such a framework should be included in the European Chemicals' Strategy for Sustainability and the data would support the Zero Pollution Action Plan.

Identifiants

pubmed: 36706581
pii: S1438-4639(23)00002-0
doi: 10.1016/j.ijheh.2023.114111
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

114111

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier GmbH.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None.

Auteurs

Joana Lobo Vicente (J)

European Environment Agency (EEA), Kongens Nytorv 6, 1050 Copenhagen K, Denmark. Electronic address: joana.lobo@eea.europa.eu.

Catherine Ganzleben (C)

European Environment Agency (EEA), Kongens Nytorv 6, 1050 Copenhagen K, Denmark.

Roser Gasol (R)

European Environment Agency (EEA), Kongens Nytorv 6, 1050 Copenhagen K, Denmark.

Ian Marnane (I)

European Environment Agency (EEA), Kongens Nytorv 6, 1050 Copenhagen K, Denmark.

Liese Gilles (L)

VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium.

Jurgen Buekers (J)

VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium.

Jos Bessems (J)

VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium.

Ann Colles (A)

VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium.

Antje Gerofke (A)

German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany.

Madlen David (M)

German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany.

Robert Barouki (R)

Université Paris Cité, Inserm T3S, Paris, France.

Maria Uhl (M)

Environment Agency, Spittelauer Lände 5, Vienna, 1090, Austria.

Ovnair Sepai (O)

United Kingdom Health Security Agency, Harwell Science Park, Chilton, OX11 0RQ, UK.

Ilse Loots (I)

University of Antwerp, Department of Sociology (CRESC and IMDO), Sint-Jacobstraat 2, 2000, Antwerp, Belgium.

Ann Crabbé (A)

University of Antwerp, Department of Sociology (CRESC and IMDO), Sint-Jacobstraat 2, 2000, Antwerp, Belgium.

Dries Coertjens (D)

University of Antwerp, Department of Sociology (CRESC and IMDO), Sint-Jacobstraat 2, 2000, Antwerp, Belgium.

Marike Kolossa-Gehring (M)

German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany.

Greet Schoeters (G)

VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium; University of Antwerp, Dept of Biomedical Sciences and Toxicological Centre, Universiteitsplein 1, 2610, Wilrijk, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH